Stroke/Cerebrovascular Disease Perspective

 
 
  • A Paradigm Shift for Preventing Stroke in Patients With Diabetes   Dr Christoph Diener on the promising new treatments that are taking aim at the deadly consequences of diabetes.
  • CAC Scores, Lp(a), CRP: CV Screening in Real Life   Lipidologists Budoff and Baum discuss real-life implications of the CAC score and how to apply it, and other measures, to everyday patients.
  • SCORED and FIDELIO-DKD: Time for Cardiologists to Help, Not Hurt, the Kidney   Nephrologist Jennie Lin and cardiologist Jane Wilcox discuss the results of SCORED and FIDELIO-DKD, presented at the AHA meeting. Can these drugs help the specialties work together to protect the kidneys?
  • How Face Masks May Be Hurting Doctors' Bedside Manner Face masks are changing doctor-patient interactions, possibly for the worse. Current and future doctors must consider how to prevent further straining this important relationship.
  • Mandrola Previews AHA 2020 A trial that aims to answer whether statin myalgia is drug related tops the picks. Studies on CT angiography, AF monitoring, fish oils, and a novel MRA will also feature at the 2020 American Heart Association meeting.
  • Oct 23 2020 This Week in Cardiology   COVID, tocilizumab, hypertrophic cardiomyopathy, cerebral microbleeds, and surrogate endpoints are the topics discussed by John Mandrola, MD, in this week’s podcast
  • Famous Patients: From Goethe to Beethoven Did you know about the physical and mental ailments of these famous artists?
  • Real-world Data and Cardiovascular Risk Reduction "Real-world data" are generated not explicitly for research but rather for clinical care. They allow for the study of treatment effectiveness and utilization in a broader population of patients and providers than evaluated in a randomized trial.
  • Practicing Cognitive Techniques Can Help Athletes Perform A look at how mental skills influence athletic performance.
  • Latest EXCEL MI Analysis Settles Nothing; Flaws Remain A new analysis from the trial comparing stents and surgery in patients with left main coronary artery disease obfuscates and distracts from the core flaws of EXCEL and its interpretation, says John Mandrola, MD.
  • Anticoagulation for COVID-19: More Harm than Good? The risk for fatal hemorrhagic stroke adds questions to the routine use of prophylactic anticoagulation in patients with COVID-19, according to Dr Andrew Wilner.
  • Sex- and Gender-Informed Medicine: Why It Matters   Dr JoAnn Manson highlights key health and disease differences influenced by sex and gender.
  • Paul Offit's Biggest Concern About COVID Vaccines   Eric Topol talks with Paul Offit about the timing of phase 3 vaccine trials, the need for public trust, and what might not be known when a vaccine rollout begins.
  • Aortic Dissection: Still the Great Masquerader Dr Amal Mattu takes a look at acute aortic dissection and explains why William Osler cautioned humility when it comes to this tricky disorder.
  • Three Doctors on Benzodiazepines and Dementia Risk   Drs Ghaemi, Larson, and Maust on why key studies to date have had difficulty establishing causation.
  • It Can All Burn A harrowing experience with her son during the COVID-19 pandemic reminds this oncology nurse that life can be forever altered in a matter of seconds.
  • ESC 2020 Seven Quick Thoughts on the New European AF Guidelines There's much to admire in the new ESC/EACTS guidelines on atrial fibrillation, but the push for opportunistic screening concerns electrophysiologist John Mandrola, MD.
  • ESC 2020 EAST-AFNET 4 Favors Rhythm Control, but It's Complicated Electrophysiologist John Mandrola, MD, cautions against oversimplifying the results of EAST-AFNET 4 to mean use more anti-arrhythmic drugs or do more ablation.
  • Mandrola Previews the Virtual ESC 2020 Trials on SGLT2 inhibitors, rhythm control in AF, and a few drugs he’s never heard of are among John Mandrola’s picks from the upcoming European Society of Cardiology Congress.
  • Are We Entitled to Know Presidential Candidates' Health Info?   Dr Art Caplan discusses the importance of transparency regarding the health of presidential candidates.